Mads Hald Andersen (Mads H Andersen)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 44

Top Venues

Oncoimmunology

Journal for immunotherapy of cancer

Seminars in immunopathology

Cancers

National Center for Cancer Immune Therapy, CCIT-DK

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Center for Cancer Immune Therapy, CCIT-DK

Denmark

Professor, dr.techn., Director :: Department of Oncology, Herlev Hospital

Publications

Sofia Bentivegna, Christophe Rm Côme, Bo Torben Porse, Mads Hald Andersen, Kirsten Grønbaek
Increased myeloid-derived suppressor cell activation in clonal cytopenia of undetermined significance and low-risk myelodysplastic syndrome. British journal of haematology (2024)
Maria Perez-Penco, Lucia Lara de la Torre, Inés Lecoq, Evelina Martinenaite, Mads Hald Andersen
TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts. Journal for immunotherapy of cancer 12 (2) (2024)
Hannah Jorinde Glöckner, Evelina Martinenaite, Thomas Landkildehus Lisle, Jacob Grauslund, Shamaila Ahmad, Özcan Met, Per Thor Straten, Mads Hald Andersen
Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells. Oncoimmunology 13 (1) (2024)
Maria Perez-Penco, Lucia Lara de la Torre, Inés Lecoq, Evelina Martinenaite, Mads Hald Andersen
TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts. Journal for immunotherapy of cancer 12 (2) (2024)
Hannah Jorinde Glöckner, Evelina Martinenaite, Thomas Landkildehus Lisle, Jacob Grauslund, Shamaila Ahmad, Özcan Met, Per Thor Straten, Mads Hald Andersen
Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells. Oncoimmunology 13 (1) (2024)
Maria Perez-Penco, Stine Emilie Weis-Banke, Aimilia Schina, Majken Siersbæk, Mie Linder Hübbe, Mia Aaboe Jørgensen, Inés Lecoq, Lucia Lara de la Torre, Simone Kloch Bendtsen, Evelina Martinenaite, Morten Orebo Holmström, Daniel Hargbøl Madsen, Marco Donia, Niels Ødum, Lars Grøntved, Mads Hald Andersen
TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer. Journal for immunotherapy of cancer 10 (12) (2023)
Maria Perez-Penco, Stine Emilie Weis-Banke, Aimilia Schina, Majken Siersbæk, Mie Linder Hübbe, Mia Aaboe Jørgensen, Inés Lecoq, Lucia Lara de la Torre, Simone Kloch Bendtsen, Evelina Martinenaite, Morten Orebo Holmström, Daniel Hargbøl Madsen, Marco Donia, Niels Ødum, Lars Grøntved, Mads Hald Andersen
TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer. Journal for immunotherapy of cancer 10 (12) (2023)
Arianna Draghi, Mario Presti, Agnete Witness Præst Jensen, Christopher Aled Chamberlain, Benedetta Albieri, Anne-Christine K Rasmussen, Mads Hald Andersen, Michael Douglas Crowther, Inge Marie Svane, Marco Donia
Uncoupling CD4+ TIL-mediated tumor killing from JAK-signaling in melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Mads Hald Andersen
Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment. Seminars in immunopathology 45 (2) (2023)
Maria Perez-Penco, Stine Emilie Weis-Banke, Aimilia Schina, Majken Siersbæk, Mie Linder Hübbe, Mia Aaboe Jørgensen, Inés Lecoq, Lucia Lara de la Torre, Simone Kloch Bendtsen, Evelina Martinenaite, Morten Orebo Holmström, Daniel Hargbøl Madsen, Marco Donia, Niels Ødum, Lars Grøntved, Mads Hald Andersen
TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer. Journal for immunotherapy of cancer 10 (12) (2023)
Mads Hald Andersen
Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment. Seminars in immunopathology 45 (2) (2023)
Rasmus Erik Johansson Mortensen, Morten Orebo Holmström, Thomas Landkildehus Lisle, Jane P Hasselby, Gro L Willemoe, Özcan Met, Inge Marie Svane, Julia Johansen, Dorte L Nielsen, Inna M Chen, Mads Hald Andersen
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy. Journal for immunotherapy of cancer 11 (3) (2023)
Mads Hald Andersen
Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment. Seminars in immunopathology 45 (2) (2023)
Rasmus Erik Johansson Mortensen, Morten Orebo Holmström, Thomas Landkildehus Lisle, Jane P Hasselby, Gro L Willemoe, Özcan Met, Inge Marie Svane, Julia Johansen, Dorte L Nielsen, Inna M Chen, Mads Hald Andersen
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy. Journal for immunotherapy of cancer 11 (3) (2023)
Hans Carl Carl Hasselbalch, Peter Junker, Vibe Skov, Lasse Kjær, Trine Alma Knudsen, Morten Kranker Larsen, Morten Orebo Holmström, Mads Hald Andersen, Christina Jensen, Morten A Karsdal, Nicholas Willumsen
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms. Cancers 15 (17) (2023)
Cathrine Lund Lorentzen, Julie Westerlin Kjeldsen, Eva Ehrnrooth, Mads Hald Andersen, Inge Marie Svane
Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab. Journal for immunotherapy of cancer 11 (5) (2023)
Mads Hald Andersen
Novel immune modulatory vaccines targeting TGFβ. Cellular & molecular immunology (2023)
Mads Hald Andersen
Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment. Seminars in immunopathology 45 (2) (2023)
Mads Hald Andersen
Novel immune modulatory vaccines targeting TGFβ. Cellular & molecular immunology (2023)
Simone Kloch Bendtsen, Maria Perez-Penco, Mie Linder Hübbe, Evelina Martinenaite, Morten Orebo Holmström, Stine Emilie Weis-Banke, Nicolai Grønne Jørgensen, Mia Aaboe Jørgensen, Shamaila Munir Ahmad, Kasper Mølgaard Jensen, Christina Friese, Mia Thorup Lundsager, Astrid Zedlitz Johansen, Marco Carretta, Niels Odum, Özcan Met, Inge Marie Svane, Daniel Hargbøl Madsen, Mads Hald Andersen
Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment. Oncoimmunology 11 (1) (2022)
Mathieu Gigoux, Morten Orebo Holmström, Roberta Zappasodi, Joseph J Park, Stephane Pourpe, Cansu Cimen Bozkus, Levi Mark Mangarin, David Redmond, Svena Verma, Sara Schad, Mariam M George, Divya Venkatesh, Arnab Ghosh, David Hoyos, Zaki Molvi, Baransel Kamaz, Anna E Marneth, William Duke, Matthew Joseph Leventhal, Max Jan, Vincent T Ho, Gabriela S Hobbs, Trine Alma Knudsen, Vibe Skov, Lasse Kjær, Thomas Stauffer Larsen, Dennis Lund Hansen, R Coleman Lindsley, Hans Carl Carl Hasselbalch, Jacob H Grauslund, Thomas L Lisle, Özcan Met, Patrick Wilkinson, Benjamin Greenbaum, Manuel A Sepulveda, Timothy A Chan, Raajit Rampal, Mads Hald Andersen, Omar Abdel-Wahab, Nina Bhardwaj, Jedd D Wolchok, Ann Mullally, Taha Merghoub
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine. Science translational medicine 14 (649) (2022)
Rahul Nandre, Vivek Verma, Pankaj Gaur, Veerupaxagouda Patil, Xingdong Yang, Zainab Ramlaoui, Nour Shobaki, Mads Hald Andersen, Ayako Wakatsuki Pedersen, Mai-Britt Zocca, Mikayel Mkrtichyan, Seema Gupta, Samir N Khleif
IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status. Cancer immunology research 10 (5) (2022)
Inés Lecoq, Katharina L Kopp, Marion Chapellier, Panagiotis Mantas, Evelina Martinenaite, Maria Perez-Penco, Lars Rønn Olsen, Mai-Britt Zocca, Ayako Wakatsuki Pedersen, Mads Hald Andersen
CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment. Oncoimmunology 11 (1) (2022)
Stine Emilie Weis-Banke, Thomas Landkildehus Lisle, Maria Perez-Penco, Aimilia Schina, Mie Linder Hübbe, Majken Siersbæk, Morten Orebo Holmström, Mia Aaboe Jørgensen, Inge Marie Svane, Özcan Met, Niels Ødum, Daniel Hargbøl Madsen, Marco Donia, Lars Grøntved, Mads Hald Andersen
Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells. Journal for immunotherapy of cancer 10 (10) (2022)
Mads Hald Andersen
Tumor microenvironment antigens. Seminars in immunopathology (2022)
Nicolai Grønne Jørgensen, Jeanette Kaae, Jacob Handlos Grauslund, Özcan Met, Signe Ledou Nielsen, Ayako Wakatsuki Pedersen, Inge Marie Svane, Eva Ehrnrooth, Mads Hald Andersen, Claus Zachariae, Lone Skov
Vaccination against PD-L1 with IO103 a Novel Immune Modulatory Vaccine in Basal Cell Carcinoma: A Phase IIa Study. Cancers 13 (4) (2021)
Mia Aaboe Jørgensen, Stefano Ugel, Mie Linder Hübbe, Marco Carretta, Maria Perez-Penco, Stine Emilie Weis-Banke, Evelina Martinenaite, Katharina Kopp, Marion Chapellier, Annalisa Adamo, Francesco De Sanctis, Cristina Frusteri, Manuela Iezzi, Mai-Britt Zocca, Daniel Hargbøll Madsen, Ayako Wakatsuki Pedersen, Vincenzo Bronte, Mads Hald Andersen
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. Cancer immunology research 9 (11) (2021)
Uffe Klausen, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund, Shamaila Munir Ahmad, Anne Ortved Gang, Evelina Martinenaite, Stine Emilie Weis-Banke, Marie Fredslund Breinholt, Guy Wayne Novotny, Julie Westerlin Kjeldsen, Morten Orebo Holmström, Lone Bredo Pedersen, Christian Bjørn Poulsen, Per Boye Hansen, Özcan Met, Inge Marie Svane, Carsten Utoft Niemann, Lars Møller Pedersen, Mads Hald Andersen
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma. Oncoimmunology 10 (1) (2021)
Uffe Klausen, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund, Shamaila Munir Ahmad, Anne Ortved Gang, Evelina Martinenaite, Stine Emilie Weis-Banke, Marie Fredslund Breinholt, Guy Wayne Novotny, Julie Westerlin Kjeldsen, Morten Orebo Holmström, Lone Bredo Pedersen, Christian Bjørn Poulsen, Per Boye Hansen, Özcan Met, Inge Marie Svane, Carsten Utoft Niemann, Lars Møller Pedersen, Mads Hald Andersen
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma. Oncoimmunology 10 (1) (2021)
Stine Emilie Weis-Banke, Mie Linder Hübbe, Morten Orebo Holmström, Mia Aaboe Jørgensen, Simone Kloch Bendtsen, Evelina Martinenaite, Marco Carretta, Inge Marie Svane, Niels Ødum, Ayako Wakatsuki Pedersen, Özcan Met, Daniel Hargbøl Madsen, Mads Hald Andersen
The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines. Oncoimmunology 9 (1) (2020)
Morten Orebo Holmström, Hans Carl Hasselbalch, Mads Hald Andersen
Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms. Cancers 12 (7) (2020)
Edda Blümel, Shamaila Munir Ahmad, Claudia Nastasi, Andreas Willerslev-Olsen, Maria Gluud, Simon Fredholm, Tengpeng Hu, Bas G J Surewaard, Lise Maria Lindahl, Hanne Fogh, Sergei B Koralov, Lise Mette Rahbek Gjerdrum, Rachael A Clark, Lars Iversen, Thorbjørn Krejsgaard, Charlotte Menné Bonefeld, Carsten Geisler, Jürgen Christian Becker, Anders Woetmann, Mads Hald Andersen, Terkild Brink Buus, Niels Ødum
Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma. Oncoimmunology 9 (1) (2020)
Morten Orebo Holmström, Mads Hald Andersen
Healthy Donors Harbor Memory T Cell Responses to RAS Neo-Antigens. Cancers 12 (10) (2020)
Edda Blümel, Andreas Willerslev-Olsen, Maria Gluud, Lise Maria Lindahl, Simon Fredholm, Claudia Nastasi, Thorbjørn Krejsgaard, Bas G J Surewaard, Sergei B Koralov, Tengpeng Hu, Jenny L Persson, Charlotte Menné Bonefeld, Carsten Geisler, Lars Iversen, Jürgen Christian Becker, Mads Hald Andersen, Anders Woetmann, Terkild Brink Buus, Niels Ødum
Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma. Oncoimmunology 8 (11) (2019)
Mads Hald Andersen
The targeting of tumor-associated macrophages by vaccination. Cell stress 3 (5) (2019)
Evelina Martinenaite, Shamaila Munir Ahmad, Simone Kloch Bendtsen, Mia Aaboe Jørgensen, Stine Emilie Weis-Banke, Inge Marie Svane, Mads Hald Andersen
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope. Cancer immunology, immunotherapy : CII 68 (11) (2019)
Marlies J W Peeters, Donata Dulkeviciute, Arianna Draghi, Cathrin Ritter, Anne Rahbech, Signe K Skadborg, Tina Seremet, Ana Micaela Carnaz Simões, Evelina Martinenaite, Hólmfridur R Halldórsdóttir, Mads Hald Andersen, Gitte Holmen Olofsson, Inge Marie Svane, Lene Juel Rasmussen, Özcan Met, Jürgen Christian Becker, Marco Donia, Claus Desler, Per Thor Straten
MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells. Cancer immunology research 7 (9) (2019)
Morten Orebo Holmström, Guy W Novotny, Jesper Petersen, Mia Aaboe-Jørgensen, Hans Carl Hasselbalch, Mads Hald Andersen, Signe Ledou Nielsen, Daniel El Fassi, Claudia Schöllkopf
Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy. Leukemia & lymphoma 60 (13) (2019)
Morten Orebo Holmström, Hans Carl Carl Hasselbalch, Mads Hald Andersen
Neo-antigen specific memory T-cell responses in healthy individuals. Oncoimmunology 8 (7) (2019)
Mads Hald Andersen
Anti-cancer immunotherapy: breakthroughs and future strategies. Seminars in immunopathology 41 (1) (2018)
Joanna Walkowska, Thomas Kallemose, Göran Jönsson, Mats Jönsson, Ove Andersen, Mads Hald Andersen, Inge Marie Svane, Anne Langkilde, Mef Christina Nilbert, Christina Therkildsen
Immunoprofiles of colorectal cancer from Lynch syndrome. Oncoimmunology 8 (1) (2018)
Mia Aaboe Jørgensen, Morten Orebo Holmström, Evelina Martinenaite, Caroline Hasselbalch Riley, Hans Carl Carl Hasselbalch, Mads Hald Andersen
Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation. Oncoimmunology 7 (9) (2018)
Mads Hald Andersen
The T-win® technology: immune-modulating vaccines. Seminars in immunopathology 41 (1) (2018)
Mads Hald Andersen
Cancer and autoimmunity. Seminars in immunopathology 39 (3) (2017)

Mads Hald Andersen.css-eqlu8i{font-size:small;padding-left:4px;} (Mads H Andersen)

Publication Activity (10 Years)

Top Topics

Top Venues

Mads Hald Andersen (Mads H Andersen)